Azithromycin for Critical Asthma - Pediatrics

Description

The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

Conditions

Pediatric Asthma, Critical Illness

Talk to us

Study Overview

On this page

Study Details

Study overview

The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

Azithromycin as Immunomodulation Among Children Hospitalized for Critical Asthma: A Prospective, Open-Label, Non-Randomized, Interventional Study With Parallel Biospecimen Banking

Azithromycin for Critical Asthma - Pediatrics

Condition
Pediatric Asthma
Intervention / Treatment

-

Contacts and Locations

Saint Petersburg

Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States, 33701

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    3 Years to 17 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Johns Hopkins All Children's Hospital,

    Anthony A Sochet, MD, PRINCIPAL_INVESTIGATOR, Johns Hopkins All Children's Hospital

    Study Record Dates

    2025-06-30